Search company, investor...

BioKangtai

biokangtai.com

Founded Year

1988

Stage

IPO | IPO

Total Raised

$26.4M

Date of IPO

2/7/2017

About BioKangtai

Manufacturer of biological products in China. The company manufactures hepatitis B vaccine that prevents liver cancer. The products are distributed in 31 provinces.

Headquarters Location

6 Kefa Road Science & Industry Park, Nanshan

Shenzhen, Guangdong, 518057,

China

86 755 26988688

Missing: BioKangtai's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: BioKangtai's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing BioKangtai

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioKangtai is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest BioKangtai News

08:00 EDT Mono Vaccine Market to Grow by USD 2.8 Bn, Meningococcal Vaccine to be Largest Revenue-generating Type Segment - Techn...

Nov 2, 2022

Share this article Share this article NEW YORK, Nov. 2, 2022 /PRNewswire/ -- The mono-vaccine market is expected to grow by USD 2.8 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 5.16% during the forecast period, according to Technavio. This growth can be attributed to the increase in the pediatric population. However, rising antimicrobial resistance can hamper the growth of the market during the next few years. View a comprehensive report summary that describes the market size and forecast along with the research methodology. The FREE sample report  is available in PDF format Rest Of World (ROW) 36% of the market's growth will originate from North America during the forecast period. The US is the key market for the mono-vaccine market in North America. The increase in the pediatric population will facilitate the mono-vaccine market growth in North America over the forecast period. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report Mono Vaccine Market 2022-2026: Vendor Analysis We provide a detailed analysis of around 25 vendors operating in the Mono Vaccine Market, including AstraZeneca Plc, Aurobindo Pharma Ltd., Bavarian Nordic AS, China National Pharmaceutical Group Corp., Dynavax Technologies Corp., GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Moderna Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Valneva SE, and VBI Vaccines Inc. The key offerings of some of these vendors are listed below: Shenzhen Kangtai Biological Products Co. Ltd. - The company, Shenzhen Kangtai Biological Products Co. Ltd. offers a mono vaccine, namely the SARS-COV 2 Vaccine. AstraZeneca Plc - The company offers mono-vaccine namely COVAX. Aurobindo Pharma Ltd. - Under this segment, the company manufactures generic pharmaceuticals and active pharmaceutical ingredients. Sanofi SA - The company offers mono vaccine through its subsidiary China National Biotec Group. Dynavax Technologies Corp. - The company offers mono-vaccine namely Heplisav B. This report provides a full list of key vendors, their strategies, and latest developments. Buy Now  to gain access to exclusive vendor information Mono Vaccine Market 2022-2026: Key Highlights CAGR of the market during the forecast period 2022-2026 Detailed information on factors that will assist mono-vaccine market growth during the next five years Estimation of the mono vaccine market size and its contribution to the parent market Predictions on upcoming trends and changes in consumer behavior The growth of the mono-vaccine market Analysis of the market's competitive landscape and detailed information on vendors Comprehensive details of factors that will challenge the growth of mono-vaccine market vendors Related Reports: Companies profiled AstraZeneca Plc, Aurobindo Pharma Ltd., Bavarian Nordic AS, China National Pharmaceutical Group Corp., Dynavax Technologies Corp., GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Moderna Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Valneva SE, and VBI Vaccines Inc. Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. Table Of Contents : Exhibit 27: Data Table on Comparison by Type 5.3 Meningococcal Vaccine - Market size and forecast 2021-2026 Exhibit 28: Chart on Meningococcal Vaccine - Market size and forecast 2021-2026 ($ million) Exhibit 29: Data Table on Meningococcal Vaccine - Market size and forecast 2021-2026 ($ million) Exhibit 30: Chart on Meningococcal Vaccine - Year-over-year growth 2021-2026 (%) Exhibit 31: Data Table on Meningococcal Vaccine - Year-over-year growth 2021-2026 (%) 5.4 Japanese Encephalitis Vaccine - Market size and forecast 2021-2026 Exhibit 32: Chart on Japanese Encephalitis Vaccine - Market size and forecast 2021-2026 ($ million) Exhibit 33: Data Table on Japanese Encephalitis Vaccine - Market size and forecast 2021-2026 ($ million) Exhibit 34: Chart on Japanese Encephalitis Vaccine - Year-over-year growth 2021-2026 (%) Exhibit 35: Data Table on Japanese Encephalitis Vaccine - Year-over-year growth 2021-2026 (%) 5.5 Hepatitis Vaccine - Market size and forecast 2021-2026 Exhibit 36: Chart on Hepatitis Vaccine - Market size and forecast 2021-2026 ($ million) Exhibit 37: Data Table on Hepatitis Vaccine - Market size and forecast 2021-2026 ($ million) Exhibit 38: Chart on Hepatitis Vaccine - Year-over-year growth 2021-2026 (%) Exhibit 39: Data Table on Hepatitis Vaccine - Year-over-year growth 2021-2026 (%) 5.6 Yellow Fever Vaccine - Market size and forecast 2021-2026 Exhibit 40: Chart on Yellow Fever Vaccine - Market size and forecast 2021-2026 ($ million) Exhibit 41: Data Table on Yellow Fever Vaccine - Market size and forecast 2021-2026 ($ million) Exhibit 42: Chart on Yellow Fever Vaccine - Year-over-year growth 2021-2026 (%) Exhibit 43: Data Table on Yellow Fever Vaccine - Year-over-year growth 2021-2026 (%) 5.7 Others - Market size and forecast 2021-2026 Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ million) Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ million) Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%) Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%) 5.8 Market opportunity by Type Exhibit 48: Market opportunity by Type ($ million) 6 Customer Landscape Exhibit 53: Data Table on Geographic comparison 7.3 North America - Market size and forecast 2021-2026 Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ million) Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ million) Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%) Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%) 7.4 Europe - Market size and forecast 2021-2026 Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ million) Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ million) Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%) Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%) 7.5 Asia - Market size and forecast 2021-2026 Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ million) Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ million) Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%) Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%) 7.6 Rest of World (ROW) - Market size and forecast 2021-2026 Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million) Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million) Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%) Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%) 7.7 US - Market size and forecast 2021-2026 Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ million) Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ million) Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%) Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%) 7.8 Germany - Market size and forecast 2021-2026 Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million) Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million) Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%) Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%) 7.9 UK - Market size and forecast 2021-2026 Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million) Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million) Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%) Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%) 7.10 France - Market size and forecast 2021-2026 Exhibit 82: Chart on France - Market size and forecast 2021-2026 ($ million) Exhibit 83: Data Table on France - Market size and forecast 2021-2026 ($ million) Exhibit 84: Chart on France - Year-over-year growth 2021-2026 (%) Exhibit 85: Data Table on France - Year-over-year growth 2021-2026 (%) 7.11 China - Market size and forecast 2021-2026 Exhibit 86: Chart on China - Market size and forecast 2021-2026 ($ million) Exhibit 87: Data Table on China - Market size and forecast 2021-2026 ($ million) Exhibit 88: Chart on China - Year-over-year growth 2021-2026 (%) Exhibit 89: Data Table on China - Year-over-year growth 2021-2026 (%) 7.12 Market opportunity by geography Exhibit 90: Market opportunity by geography ($ million) 8 Drivers, Challenges, and Trends 8.1 Market drivers Exhibit 91: Impact of drivers and challenges in 2021 and 2026 8.4 Market trends 9.3 Landscape disruption 9.4 Industry risks About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact

BioKangtai Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

BioKangtai Rank

BioKangtai Frequently Asked Questions (FAQ)

  • When was BioKangtai founded?

    BioKangtai was founded in 1988.

  • Where is BioKangtai's headquarters?

    BioKangtai's headquarters is located at 6 Kefa Road, Shenzhen.

  • What is BioKangtai's latest funding round?

    BioKangtai's latest funding round is IPO.

  • How much did BioKangtai raise?

    BioKangtai raised a total of $26.4M.

  • Who are the investors of BioKangtai?

    Investors of BioKangtai include Huagai Capital, Fortune United Partners, CMB International Capital, Frontline BioVentures, Shengshang and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.